Fed Sparks Profit T...
Health Care: Drugs
Endo Health Solutions Inc (ENDP: NASDAQ)
$33.88 -0.40 | -1.17%
05/24/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 33.88 |
| 52 Week High | 38.32 |
| 52 Week Low | 25.01 |
| Avg. Daily Vol. (Mil) | 2.58 |
| Beta (3 year) | 1.19 |
| Share Related Items | |
| Mkt Cap (Mil) | 3,802.72 |
| Shares Out (Mil) | 112.24 |
| Float (Mil) | 97.51 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.80 |
| Current Ratio | 1.30 |
| LT Debt/ Equity | 2.70 |
| Total Debt / Equity | 2.76 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.25 |
| Price/Book | 3.41 |
| Price/Cash Flow | -14.50 |
| Per Share Data | |
| Earnings | -5.52 |
| Sales | 27.13 |
| Book Value | 9.93 |
| Cash Flow | -2.34 |
| Business Summary | |
|---|---|
| Endo Health Solutions Inc operates as a specialty pharmaceutical company. The Company researches, develops, sells and markets branded and generic prescription pharmaceuticals used to treat and manage pain. | |
| General Information | |
| 1400 Atwater Drive
Malvern, PA 19317 |
|
| www.endo.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 4629 | |
| CEO: Mr. Rajiv De Silva | |
| Short Interest | |
| Current Month (Mil) | 10.07 |
| Previous Month (Mil) | 8.82 |
| Short Interest Ratio (Days) | 3.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -9.20 |
| Return on Investments | -14.00 |
| Profitability | |
| Gross Margin | 71.80 |
| EBIT Margin | -13.50 |
| Profit Margin | -19.30 |
Portfolios with ENDP
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ProJoel Greenblatt - Gotham Ca...
- ProSteven Cohen - SAC Capital
- ProLee Ainslie - Maverick Capital
- ContributorStocks Rising On Unusual Vo...
- ProD.E. Shaw
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
Latest ENDP Headlines from TheStreet
- Endo Health Stock Hits New 52-Week High (ENDP) 04.19.13 | 12:04 pm
- Endo Health Rises On Unusually High Volume (ENDP) 04.17.13 | 03:04 pm
- 4 Stocks Rising on Unusual Volume 04.17.13 | 03:04 pm
- Today's Drugs Industry Featured Laggard: Endo Health Solutions Inc (ENDP) 04.10.13 | 05:04 pm
- Endo Health Rises On Unusually High Volume (ENDP) 04.03.13 | 04:04 pm
- Endo Health Solutions Inc Stock Downgraded (ENDP) 03.04.13 | 04:03 am
- 4 Stocks Rising on Unusual Volume 02.25.13 | 03:02 pm
- Endo Health Rises On Unusually High Volume (ENDP) 02.25.13 | 11:02 am
- Endo Health Solutions Inc (ENDP): Today's Featured Health Care Laggard 02.14.13 | 05:02 pm
- Endo Health Rises On Unusually High Volume (ENDP) 01.30.13 | 03:01 pm
Press Releases for ENDP
- Endo Health Solutions Responds To FDA's Denial Of OPANA® ER Citizen Petition And The Potential Approval Of Additional Non-Abuse Deterrent Formulations Of Generic Oxymorphone - PR Newswire 05.10.13 | 04:05 pm
- First Head-to-Head Study Shows GreenLight XPS® Laser Therapy Equally Safe And Effective With Faster Recovery As Commonly Used TURP For Treatment Of BPH - PR Newswire 05.06.13 | 04:05 pm
- Endo To Announce First Quarter 2013 Financial Results On May 7, 2013 - PR Newswire 04.15.13 | 04:04 pm
- Endo Health Solutions To Present At The Cowen And Company 33rd Annual Health Care Conference - PR Newswire 03.05.13 | 11:03 am
- Rajiv De Silva Named President And CEO Of Endo Health Solutions - PR Newswire 02.25.13 | 08:02 am
- Endo To Announce Fourth Quarter 2012 Financial Results On February 28, 2013 - PR Newswire 02.13.13 | 03:02 pm
- Endo Health Solutions Reaffirms 2012 Adjusted Earnings Per Share Outlook And Provides 2013 Financial Guidance - PR Newswire 01.03.13 | 04:01 pm
- Endo Health Solutions Comments On Dismissal Of Suit Against FDA - PR Newswire 12.19.12 | 05:12 pm
- Endo Health Solutions Announces CEO Transition Plan - PR Newswire 12.12.12 | 05:12 pm
- Endo Health Solutions Launches 7.5mg And 15mg Strengths Of Reformulated, Designed To Be Crush-Resistant, OPANA® ER - PR Newswire 12.11.12 | 12:12 pm
Partner Headlines for ENDP
- After-Hours Earnings Report for February 28, 2013 : CRM, GPS, UHS, TEG, NGD, WR, MDVN, ENDP, GXP, MDR, CPNO, SLXP - NASDAQ 02.28.13 | 07:02 pm
- After Hours Most Active for Feb 27, 2013 : F, GRPN, JCI, ABT, ABBV, JCP, GTAT, QQQ, BAC, TLAB, ENDP, ACWI - NASDAQ 02.27.13 | 09:02 pm
- Stock Market News for November 13, 2012 - Market News - Zacks 11.13.12 | 10:11 am
- ENDP Beats on Earnings, View Lowered - Analyst Blog - Zacks 11.06.12 | 09:11 am
- Watson Pharma Starts New Era As Generic Drug Titan - Investor's Business Daily 11.02.12 | 04:11 pm
- After Hours Most Active for Oct 15, 2012 : CIM, C, KMI, GOV, GEN, S, SIRI, CELL, MSFT, QQQ, ENDP, QCOM - NASDAQ 10.15.12 | 08:10 pm
- Update on Repros' Androxal - Analyst Blog - NASDAQ 09.14.12 | 09:09 pm
- Update on Repros' Androxal - Analyst Blog - Zacks 09.14.12 | 06:09 pm
- Watson's Generic Lidoderm Approved - Analyst Blog - NASDAQ 08.27.12 | 09:08 pm
- After Hours Most Active for Aug 27, 2012 : BAC, T, BSX, PBR/A, GFA, PSSI, SCS, QQQ, CSGS, VRSN, ENDP, DELL - NASDAQ 08.27.12 | 08:08 pm
